Option delistings effective December 23rd include Pieris Pharmaceuticals (PVLA), Nanostring Technologies, Inc. (NSTGQ), NaaS Technology (NAAS), ROUNDHILL DAILY INVERSE MAGNIFICENT SEVEN ETF (MAGQ), Merrimack Pharmaceuticals Inc (MACK), Cue Health Inc (HLTHQ), Galera Therapeutics Inc (GRTX), DermTech Inc (DMTKQ), Cidara Therapeutics (CDTX), Nuburu, Inc. (BURU), Atara Biotherapeutics (ATRA), and RCM Technologies (RCMT).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PVLA: